Thursday, 15 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleMIT Technology Review

Building tech in the world’s secret R&D hub

View original at technologyreview.com
MIT Technology Review - Ai Research Title: Building tech in the world’s secret R&D hub Date: 2026-06-30 10:23 Source: https://www.technologyreview.com/2026/06/30/1139661/building-tech-in-the-worlds-secret-rd-hub/ <p>Apple…
Opening lines of the source · MIT Technology Review · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Switzerland ranked number 1 in the IMD World Talent Ranking for the 10th consecutive year, leading globally in investment, development, and talent appeal

    60% confidence
  • The Zurich AI Festival will bring together more than 6,500 guests from September 28 to October 3 with more than 35 confirmed events

    60% confidence
  • Over 60% of Swiss venture capital is invested in deep tech—the highest share globally by a large margin and nearly twice the share of major economies like Germany, France, and the UK

    60% confidence
  • Switzerland ranks first globally for AI researchers and inventors per capita, with 110.5 per 100,000 inhabitants—ahead of Singapore (109.5), Sweden (80.6), and the United States (64.8)

    60% confidence
  • Greater Zurich Area has higher Big Tech density than Silicon Valley in certain areas

    60% confidence
  • Switzerland leads the world in patents per capita

    60% confidence
  • At $1,470 invested per capita, Switzerland commits more to deep tech per capita than any other country in Europe

    60% confidence
  • Switzerland invests over 3.3% of GDP in research and development

    60% confidence
  • Switzerland has ranked first in the Global Innovation Index for more than a decade

    60% confidence
  • ETH Zurich ranks among Europe's leading universities for deep tech commercialization, generating more than 40 spin-offs and startups in 2025 alone

    60% confidence
  • This content was produced by the Greater Zurich Area and was not written by MIT Technology Review's editorial staff

    60% confidence
  • Google engineers teach at ETH Zurich, and ETH graduates join companies such as Anthropic

    60% confidence
  • To assemble the greatest search team in the world, Exa.ai must be where the top talent is, and many of those people are in Greater Zurich

    60% confidence
  • Silicon Valley remains unmatched in scale, venture capital, and frontier model development, but Switzerland serves as a strategic complement for accessing specialized talent and leading research

    60% confidence
  • Former Google Switzerland employees alone have founded approximately 210 companies and created around 2,600 jobs over the past two decades

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com